New hope for Tough-to-Treat lymphoma: testing a modified drug schedule
NCT ID NCT05222555
Summary
This study is testing a new, modified dosing schedule for a drug combination (tafasitamab plus lenalidomide) in patients whose diffuse large B-cell lymphoma has come back or hasn't responded to prior treatments. The main goals are to check the safety of this new schedule and see how the drug moves through the body. It is for adults who have had 1 to 3 prior treatments and are not eligible for a stem cell transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASST Grande Ospedale Metropolitano Niguarda - Presidio Ospedaliero Ospedale Niguarda
Milan, Lombardy, 20162, Italy
-
ASST di Monza - Azienda Ospedaliera San Gerardo
Monza, Monza E Brianza, 20900, Italy
-
Asan Medical Center - PPDS
Seoul, 5505, South Korea
-
Azienda Ospedaliera di Perugia
Perugia, Umbria, 6122, Italy
-
Azienda Ospedaliero Universitaria Pisana
Pisa, Tuscany, 56127, Italy
-
CHU Nantes
Nantes, Loire-Atlantique, 44000, France
-
CHU de Poitiers
Poitiers, Vienne, 86021, France
-
Centre Hospitalier Le Mans
Le Mans, Sarthe, 72000, France
-
Centre Hospitalier Universitaire Grenoble Alpes - Hopital Albert Michallon
Grenoble, Isère, 38043, France
-
Centrum Medyczne Poznan - PRATIA - PPDS
Skórzewo, Greater Poland Voivodeship, 60-185, Poland
-
Chonbuk National University Hospital
Jeonju, 54907, South Korea
-
Complejo Asistencial Universitario de Salamanca - H. Clinico
Salamanca, 37007, Spain
-
Daegu Catholic University Medical Center
Daegu, 42472, South Korea
-
Dolnoslaskie Centrum Onkologii, Pulmonologii i Hematologii
Wroclaw, Lower Silesian Voivodeship, 53-439, Poland
-
Dong-A University Medical Center
Busan, 49201, South Korea
-
Fakultni nemocnice Brno
Brno, 625 00, Czechia
-
Fakultni nemocnice Kralovske Vinohrady
Prague, 100 34, Czechia
-
Fakultni nemocnice Ostrava
Ostrava, 708 52, Czechia
-
Fakultni nemocnice v Motole
Prague, 150 06, Czechia
-
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan, Lombardy, 20122, Italy
-
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Lombardy, 27100, Italy
-
Fondazione del Piemonte per l'Oncologia (IRCCS)
Candiolo, Piedmont, 10060, Italy
-
Gachon University Gil Medical Center
Incheon, 21565, South Korea
-
Hadassah Medical Center - Hadassah Ein Kerem
Jerusalem, 91120, Israel
-
Hanyang University Medical Center
Seoul, 4763, South Korea
-
Hospital Son Llatzer
Palma de Mallorca, Balearic Islands, 7198, Spain
-
Hospital U. Infanta Leonor
Madrid, 28031, Spain
-
Hospital U. Quironsalud Madrid
Madrid, 28223, Spain
-
Hospital U. Ramon y Cajal
Madrid, 28034, Spain
-
Hospital U. Virgen del Rocio
Seville, 41013, Spain
-
Hospital Universitari La Fe
Valencia, 46026, Spain
-
Hospital Universitario Fundacion Jimenez Diaz
Madrid, 28040, Spain
-
ICO l'Hospitalet - Hospital Duran i Reynals
L'Hospitalet de Llobregat, 8907, Spain
-
Institut Catala d'Oncologia Girona
Girona, 17007, Spain
-
Klinikum Wels Grieskirchen
Wels, Upper Austria, 4600, Austria
-
Kosin University Gospel Hospital
Busan, 49267, South Korea
-
Lady Davis Carmel Medical Center
Haifa, 34362, Israel
-
MD Anderson Madrid
Madrid, 28033, Spain
-
Morristown Memorial Hospital
Morristown, New Jersey, 07960-6459, United States
-
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy
Warsaw, Masovian Voivodeship, 02-781, Poland
-
Nasz Lekarz Osrodek Badan Klinicznych
Torun, 87-100, Poland
-
Ospedale Santa Maria Delle Croci
Ravenna, Emilia-Romagna, 48121, Italy
-
Pratia MCM Krakow
Krakow, Lesser Poland Voivodeship, 30-510, Poland
-
Pusan National University Hospital
Busan, 49241, South Korea
-
SP ZOZ Szpital Uniwersytecki w Krakowie
Krakow, 31-501, Poland
-
SPZOZ MiSWiA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie
Olsztyn, 10-228, Poland
-
Shamir Medical Center Assaf Harofeh
Be’er Ya‘aqov, 70300, Israel
-
Soroka University Medical Centre
Beersheba, Southern District, 84101, Israel
-
Szpital Wojewodzki w Opolu
Opole, Opole Voivodeship, 45-061, Poland
-
Szpitale Pomorskie Sp. z o. o.
Gdynia, 81-519, Poland
-
Texas Oncology-Baylor Charles A. Sammons Cancer Center - USOR
Dallas, Texas, 75246-2092, United States
-
The Catholic University of Korea, St. Vincent's Hospital
Suwon, Gyeonggido, 16247, South Korea
-
The Catholic University of Korea, Yeouido St. Mary's Hospital
Seoul, 7345, South Korea
-
UK St. Pölten
Sankt Pölten, Lower Austria, 3100, Austria
-
Ulsan University Hospital
Ulsan, 44033, South Korea
-
Universitatsklinikum Salzburg
Salzburg, 5020, Austria
-
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza Radeckiego we Wroclawiu
Wroclaw, Lower Silesian Voivodeship, 50-367, Poland
-
Vista Oncology
Olympia, Washington, 98506, United States
-
Vseobecna Fakultni Nemocnice V Praze
Prague, 128 08, Czechia
-
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi
Lodz, 93-513, Poland
-
Yeungnam University Hospital
Daegu, 42415, South Korea
-
ZIV Medical Center
Safed, 13100, Israel
Conditions
Explore the condition pages connected to this study.